RK

Rajiv Kumar

Active Director Director DIN 06540430
DIN 06540430 First appointment Apr 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2013
Shareholding value •••• Premium profile

About Rajiv Kumar

Data last updated:

Rajiv Kumar is a Director at Vagus Remedies Private Limited (since 2013). The company operates in Trading. Vagus Remedies Private Limited reported revenue of ₹3.6 Lakh (FY 2019).

DIN 06540430
Primary Designation Director
Industry Trading
First Appointment 03 Apr 2013
Oldest Company Age 13 yrs
Largest company Vagus Remedies Private Limited · ₹3.6 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vagus Remedies Private Limited U24232PB2013PTC037304
Director03 Apr 20132013₹3.6 Lakh (FY 2019)Active

Board colleagues of Rajiv Kumar

NameDINCompanyDesignation
Ankur Kansal08091470Vagus Remedies Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Vagus Remedies Private Limited
Premium access

Shareholding and investment profile for Rajiv Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Kumar

Rajiv Kumar currently holds 1 directorship: Vagus Remedies Private Limited (Director, since 03 Apr 2013, revenue ₹3.6 Lakh (FY 2019)).

Rajiv Kumar was first appointed on 03 Apr 2013 as Director at Vagus Remedies Private Limited.

The current boards of Rajiv Kumar's companies include Ankur Kansal (Vagus Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available